Olema Pharmaceuticals Statistics
Total Valuation
OLMA has a market cap or net worth of $280.85 million. The enterprise value is -$151.81 million.
Important Dates
The last earnings date was Tuesday, March 18, 2025, after market close.
Earnings Date | Mar 18, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
OLMA has 68.33 million shares outstanding. The number of shares has increased by 29.83% in one year.
Current Share Class | 68.33M |
Shares Outstanding | 68.33M |
Shares Change (YoY) | +29.83% |
Shares Change (QoQ) | +14.90% |
Owned by Insiders (%) | 4.59% |
Owned by Institutions (%) | 65.01% |
Float | 41.11M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.75 |
P/TBV Ratio | 0.69 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.50, with a Debt / Equity ratio of 0.00.
Current Ratio | 10.50 |
Quick Ratio | 10.45 |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -39.07% and return on invested capital (ROIC) is -26.67%.
Return on Equity (ROE) | -39.07% |
Return on Assets (ROA) | -24.43% |
Return on Invested Capital (ROIC) | -26.67% |
Return on Capital Employed (ROCE) | -34.76% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.35M |
Employee Count | 96 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -63.30% in the last 52 weeks. The beta is 2.12, so OLMA's price volatility has been higher than the market average.
Beta (5Y) | 2.12 |
52-Week Price Change | -63.30% |
50-Day Moving Average | 4.99 |
200-Day Moving Average | 9.55 |
Relative Strength Index (RSI) | 37.74 |
Average Volume (20 Days) | 939,691 |
Short Selling Information
The latest short interest is 8.69 million, so 12.71% of the outstanding shares have been sold short.
Short Interest | 8.69M |
Short Previous Month | 8.47M |
Short % of Shares Out | 12.71% |
Short % of Float | 21.13% |
Short Ratio (days to cover) | 11.26 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -142.26M |
Pretax Income | -109.63M |
Net Income | -129.47M |
EBITDA | -141.87M |
EBIT | -142.26M |
Earnings Per Share (EPS) | -$2.20 |
Full Income Statement Balance Sheet
The company has $434.09 million in cash and $1.43 million in debt, giving a net cash position of $432.66 million or $6.33 per share.
Cash & Cash Equivalents | 434.09M |
Total Debt | 1.43M |
Net Cash | 432.66M |
Net Cash Per Share | $6.33 |
Equity (Book Value) | 408.96M |
Book Value Per Share | 5.50 |
Working Capital | 396.72M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$104.35 million and capital expenditures -$159,000, giving a free cash flow of -$104.51 million.
Operating Cash Flow | -104.35M |
Capital Expenditures | -159,000 |
Free Cash Flow | -104.51M |
FCF Per Share | -$1.53 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |